CMC Pharma Solutions promotes the visit of Canè Directors to reference medical centers in Buenos Aires

30 May, 2023

Mr. Paolo Canè and Mr. Claudio Canè, Managing Directors of CANÈ MEDICAL TECHNOLOGY, visited the hospital of the Centro Gallego de Buenos Aires.
They have been received by Dr. Adrían Lescano and his team.

Mr. Paolo Canè and Mr. Claudio Canè with Dr. Adrían Lescano and his team from Centro Gallego de Buenos Aires

Currently, Dr. Lescano, Director of the Council of Heart Failure and Pulmonary Hypertension of the Argentinian Society of Cardiology, is one of the main prescribers of treprostinil to patients diagnosed with PAH, with subcutaneous infusion through the CRONO SC ambulatory infusion pump of CANÈ MEDICAL TECHNOLOGY.



Paolo and Claudio Canè were also able to visit the INEBA (Institute of Neurosciences Buenos Aires) during their stay in Buenos Aires.
They have been received by Dr. Emilia Gatto and Dr. José Luis Etcheverry, responsible for the Parkinson’s Disease and Abnormal Movements Area of INEBA.

Frédéric Beauthier, CMC; Liana Schiavone, BIODEC; Jorge Luis Grossmüller, CELNOVA PHARMA; Ernesto Silman, BIODEC; Claudio Canè; Dra. Emilia Gatto; Paolo Canè; Dr. José Luis Etcheverry; Héctor Rodríguez, CELNOVA PHARMA

Dr. Etcheverry, neurologist, specialist in Parkinson’s disease and other movement disorders, is one of the main prescribers of apomorphine in ampoules to patients treated for Parkinson’s disease, with subcutaneous infusion through the CRONO PAR4 20 ambulatory infusion pump of CANÈ MEDICAL TECHNOLOGY.

Do you want to know more about this post?

Please contact us